niacin and warfarin

niacin has been researched along with warfarin in 22 studies

Research

Studies (22)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (31.82)	18.7374
1990's	2 (9.09)	18.2507
2000's	4 (18.18)	29.6817
2010's	9 (40.91)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Catron, PW; Flynn, ET	1
Cisar, LA; Kostis, JB; Philipp, CS; Saidi, P	1
Davis, KB; Egan, DA; Garg, R; Griffin, B; Pettinger, MB; Thomason, T; Waclawiw, MA	1
Applegate, WB; Chesney, CM; Davis, KB; Elam, MB; Garg, R; Herd, JA; Hunninghake, D; Kennedy, JW	1
Applegate, WB; Crouse, JR; Davis, KB; Egan, D; Elam, MB; Garg, R; Herd, JA; Hunninghake, DB; Johnson, WC; Kennedy, JW; Kostis, JB; Sheps, DS	1
Davidson, MH	1
THIES, HA	1
DE NICOLA, P; FUMAROLA, D	1
AVANZI, G; MENEGHINI, P	1
FONTAINE, L; PERRIN, A; SAINT-PIERRE, A	1
MARTINI, V	1
MARNAY, C	1
Christopher, A	1
Fang, DC; Gong, B; He, L; Li, M; Ma, S; Ning, B	1

Reviews

3 review(s) available for niacin and warfarin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Adjuvant drug therapy for decompression sickness: a review. Undersea biomedical research, 1982, Volume: 9, Issue:2 Topics: Adrenal Cortex Hormones; Animals; Anti-Arrhythmia Agents; Aspirin; Bronchodilator Agents; Coumarins; Cyproheptadine; Decompression Sickness; Dextrans; Diazepam; Dipyridamole; Fluid Therapy; Heparin; Humans; Indomethacin; Levodopa; Niacin; Vasoconstrictor Agents; Vasodilator Agents	1982
Does differing metabolism by cytochrome p450 have clinical importance? Current atherosclerosis reports, 2000, Volume: 2, Issue:1 Topics: Anticoagulants; Arteriosclerosis; Calcium Channel Blockers; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Mixed Function Oxygenases; Niacin; Polymorphism, Genetic; Risk Factors; Warfarin	2000

Trials

4 trial(s) available for niacin and warfarin

Article	Year
Effect of niacin supplementation on fibrinogen levels in patients with peripheral vascular disease. The American journal of cardiology, 1998, Sep-01, Volume: 82, Issue:5 Topics: Adult; Antioxidants; Arterial Occlusive Diseases; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Female; Fibrinogen; Hemodynamics; Humans; Hypolipidemic Agents; Ischemia; Leg; Male; Middle Aged; Niacin; Warfarin	1998
Compliance to multiple interventions in a high risk population. Annals of epidemiology, 1999, Volume: 9, Issue:7 Topics: Adult; Aged; Anticholesteremic Agents; Anticoagulants; Antioxidants; Aspirin; Data Interpretation, Statistical; Double-Blind Method; Female; Humans; Male; Niacin; Patient Compliance; Peripheral Vascular Diseases; Placebos; Platelet Aggregation Inhibitors; Pravastatin; Time Factors; Warfarin	1999
Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT). American heart journal, 2000, Volume: 140, Issue:4 Topics: Aged; Anticoagulants; Antioxidants; Arterial Occlusive Diseases; Ascorbic Acid; beta Carotene; Blood Coagulation; Disease Progression; Drug Therapy, Combination; Feasibility Studies; Female; Fibrinogen; Humans; Male; Niacin; Vitamin E; von Willebrand Factor; Warfarin	2000
Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial disease. American heart journal, 2000, Volume: 140, Issue:5 Topics: Aged; Anticholesteremic Agents; Anticoagulants; Antioxidants; Arteriosclerosis; Aspirin; Cholesterol, LDL; Feasibility Studies; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Niacin; Platelet Aggregation Inhibitors; Pravastatin; Risk Factors; Self Medication; Time Factors; Treatment Outcome; Triglycerides; Vitamins; Warfarin	2000

Other Studies

15 other study(ies) available for niacin and warfarin

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
[Effect of significance of combination of a rare element with dicoumarins]. Bruns' Beitrage zur klinischen Chirurgie, 1953, Volume: 187, Issue:2 Topics: Coumarins; Dicumarol; Elements; Isomerism; Niacin; Nicotinic Acids	1953
[Interpretation of the hemophilia-like findings caused by indirect anticoagulants (coumarinic, indandionic) on the basis of thromboelastographic and histological data]. Haematologica, 1957, Volume: 42, Issue:3 Topics: Anticoagulants; Blood Coagulation; Coumarins; Hemophilia A; Humans; Niacin; Nicotinic Acids; Thrombelastography	1957
[INDIRECT ANTICOAGULANT-FIBRINOLYTIC TREATMENT IN THROMBOSIS]. Sangre, 1964, Volume: 17 Topics: Anticoagulants; Coumarins; Drug Therapy; Inositol; Niacin; Nicotinic Acids; Thrombolytic Therapy; Thrombosis	1964
[FIBRINOLYTIC CHEMOTHERAPY. FIRST RESULTS OF A PERSONAL EXPERIENCE]. Lyon medical, 1964, Dec-20, Volume: 212 Topics: Biomedical Research; Coumarins; Drug Therapy; Fibrinolysis; Heparin; Injections, Intravenous; Niacin; Nicotinic Acids; Thrombolytic Therapy; Thrombosis; Toxicology	1964
[Factors of growth and metamorphosis of tadpoles. IV. Action of nicotinamide and coumarin]. Bollettino della Societa italiana di biologia sperimentale, 1950, Volume: 26, Issue:7 Topics: Animals; Coumarins; Growth; Humans; Larva; Metamorphosis, Biological; Niacin; Niacinamide	1950
[Study of the relations between tryptophan and nicotinic acid: action of indol-acrylic acid, of coumarin, of 2-methylnaphthoquinone, and of beta-hydroxy-phenylalanine on Escherichia coli]. Bulletin de la Societe de chimie biologique, 1951, Volume: 33, Issue:1-2 Topics: Acrylates; Coumarins; Escherichia coli; Niacin; Nicotinic Acids; Phenylalanine; Tryptophan; Vitamin K 3	1951
Critically elevated INR in a patient on warfarin after increase in extended-release niacin dose. The Annals of pharmacotherapy, 2011, Volume: 45, Issue:11 Topics: Aged; Anticoagulants; Delayed-Action Preparations; Drug Interactions; Female; Humans; International Normalized Ratio; Niacin; Vasodilator Agents; Warfarin	2011
The rational design of a highly sensitive and selective fluorogenic probe for detecting nitric oxide. Chemical communications (Cambridge, England), 2014, Jun-21, Volume: 50, Issue:49 Topics: Animals; Cell Line, Tumor; Coumarins; Dihydropyridines; Electron Transport; Fluorescent Dyes; Hydrogen-Ion Concentration; Mice; Microscopy, Fluorescence; Niacin; Nitric Oxide; Reactive Nitrogen Species; Reactive Oxygen Species; Spectrometry, Fluorescence	2014

chemdatabank.com